S. Jing

发表

Therapeutic and Immunoregulatory Effects of Tacrolimus in Patients with Refractory Generalized Myasthenia Gravis

Yan Wang, J. Xi, Chongbo Zhao, 2020, European Neurology.

Berberine attenuates experimental autoimmune myasthenia gravis via rebalancing the T cell subsets

S. Luo, J. Xi, Chongbo Zhao, 2021, Journal of Neuroimmunology.

Responsiveness to low-dose rituximab in refractory generalized myasthenia gravis

C. Quan, J. Xi, Chongbo Zhao, 2017, Journal of Neuroimmunology.

Effect of low-dose rituximab treatment on T- and B-cell lymphocyte imbalance in refractory myasthenia gravis

C. Quan, S. Luo, J. Xi, 2019, Journal of Neuroimmunology.

Low‐dose rituximab every 6 months for the treatment of acetylcholine receptor–positive refractory generalized myasthenia gravis

J. Xi, Liang Wang, Huahua Zhong, 2019, Muscle & nerve.

Low-dose rituximab lowers serum Exosomal miR-150-5p in AChR-positive refractory myasthenia gravis patients

S. Luo, J. Xi, Huahua Zhong, 2020, Journal of Neuroimmunology.

A Case Report of Adult-Onset Alexander Disease with a Tumor-Like Lesion in the Lateral Ventricle

T. Cai, Jianjun Wu, Ying Li, 2021, Case Reports in Neurology.

Isaacs syndrome with CASPR2 antibody: A series of three cases

C. Quan, J. Xi, Jie Song, 2017, Journal of Clinical Neuroscience.

A predictive nomogram for short‐term outcomes of myasthenia gravis patients treated with low‐dose rituximab

S. Luo, J. Xi, X. Huan, 2024, CNS neuroscience & therapeutics.